SCIENTIFIC INDUSTRIES INC

For the period ended Sep 30, 2025. Filed Nov 19, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 19, 2025

SCNDStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

	As of September 30, 2025	As of December 31, 2024
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$1,162,600	$587,900
Investment securities	7,131,100	1,985,000
Trade accounts receivable, less allowance for doubtful accounts of $15,600 at September 30, 2025 and December 31, 2024	677,600	589,000
Inventories	2,044,000	2,059,200
Income tax receivable	73,600	73,600
Prepaid expenses and other current assets	691,800	261,600
Current Assets of Discontinued Operations	108,000	2,731,400
Total current assets	11,888,700	8,287,700
Property and equipment, net	765,600	769,500
Goodwill	115,300	115,300
Other intangible assets, net	449,300	746,000
Inventories	505,700	509,500
Operating lease right-of-use assets	773,600	947,900
Other assets	59,200	63,100
Noncurrent Assets of Discontinued Operations	-	121,800
Total assets	$14,557,400	$11,560,800
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$515,100	$286,100
Accrued expenses	577,600	567,000
Contract liabilities	105,200	63,500
Lease liabilities, current portion	277,800	307,300
Liabilities of discontinued operations	77,800	523,100
Total current liabilities	1,553,500	1,747,000
Lease liabilities, less current portion	542,200	694,400
Total liabilities	2,095,700	2,441,400
Shareholders’ equity:
Common stock, $0.05 par value; 30,000,000 shares authorized; 11,928,599, shares issued and outstanding at September 30, 2025 and 10,503,599 shares issued and outstanding at December 31, 2024	596,400	525,200
Additional paid-in capital	44,966,900	42,637,800
Accumulated other comprehensive gain (loss)	136,700	(113,100)
Accumulated deficit	(33,238,300)	(33,930,500)
Total shareholders’ equity	12,461,700	9,119,400
Total liabilities and shareholders’ equity	$14,557,400	$11,560,800

See notes to unaudited condensed consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.